TESTICULAR TUMORS IN PEDIATRIC POPULATION: SINGLE CENTER EXPERIENCE
Abstract
Our study aims to provide valuable contributions to the understanding and management of this rare condition, with a particular focus on our single-center experience and analysis of cases in light of limited worldwide reports. Materials and methods: This study analyzed 18 patients between 2003 and 2023. We categorized patients into two age groups: prepubertal (ages 0-11 yrs.) and postpubertal (ages 12- 18 yrs.), based on the typical onset of puberty in males, in order to compare distinct tumor characteristics. We assessed clinical data, staging imaging, pre-operative serum tumor marker values, surgical approaches, chemotherapy protocols, and clinical outcomes. Results: There was no significant difference in the prevalence of the different types of clinical presentations between groups. The overall survival (OS) rate was 94.4%, while the progression free survival (PFS) was 77.8%. The postpubertal age group had a significantly lower PFS period compared to patients in the prepubertal age group. Conclusions: This research highlights the importance of precisely performing physical, imaging, and biological tests for the early detection of testicular cancer. It emphasizes the significance of ongoing research and collaborative efforts to enhance testicular cancer management.
References
2. SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2023 Apr 19. [updated: 2023 Jun 8; cited 2023 Jul 24]. Available from: https://seer.cancer.gov/statistics-network/explorer/. Data source(s): SEER Incidence Data, No-vember 2022 Submission (1975-2020), SEER 22 registries (excluding Illinois and Massachusetts). Expected Survival Life Tables by Socio-Economic Standards.
3. Poynter JN, Amatruda JF, Ross JA. Trends in Incidence and Survival of Pediatric and Adolescent Patients with Germ Cell Tumors in the United States, 1975 to 2006. Cancer 2010, 116 (20): 4882-4891.
4. Ciongradi CI, Sârbu I, Iliescu Halițchi CO, Benchia D, Sârbu K. Fertility of Cryptorchid Testis an Unsolved Mistery. Genes (Basel) 2021; 12(12): 1894.
5. Suominen JS, Jawaid WB, Losty PD. Testicular Microlithiasis and Associated Testicular Malignancies in Childhood: A Systematic Review. Pediatr. Blood Cancer 2015; 62(3): 385-388.
6. Metcalfe PD, Farivar-Mohseni H, Farhat W, McLorie G, Khoury A, Bägli DJ. Pediatric Testicular Tumors: Contemporary Incidence and Efficacy of Testicular Preserving Surgery. J. Urol. 2003; 170(6): 2412-2416.
7. Oldenburg J, Fosså SD, Nuver J, et al. Testicular Seminoma and Non-Seminoma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Ann Oncol 2013; 24: vi125-vi132.
8. Cost NG, Lubahn JD, Adibi M, et al. A Comparison of Pediatric, Adolescent, and Adult Testicular Germ Cell Malignancy:Pediatric, Adolescent, and Adult Testicular GCTs. Pediatr Blood Can-cer 2014; 61(3): 446-451.
9. Grady, RW, Ross, JH, Kay, R. Patterns of Metastatic Spread in Prepubertal Yolk Sac Tumor of the Testis. J Urol 1995; 153(4): 1259-1261.
10. Horton Z, Schlatter, M, Schultz, S. Pediatric Germ Cell Tumors. Surg Oncol 2007, 16 (3), 205-213.
11. O’Shea K, Tong A, Farrell, P, et al. Management and Outcome of Pediatric Testicular Tumors - A 20 Year Experience. J Pediatr Surg 2021, 56 (11), 2032-2036.
12. Hartke DM, Agarwal PK, Palmer JS. Testicular Neoplasms in the Prepubertal Male. J Mens Health Gend 2006; 3(2): 131-138.
13. Joice GA, Rowe SP, Gorin MA, Pierorazio PM. Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases. Curr Urol Rep 2018; 19(12): 110.
14. Dalal PU. Imaging of Testicular Germ Cell Tumours. Cancer Imaging 2006; 6(1): 124-134.
15. von Schulthess, GK, Steinert HC, Hany TF. Integrated PET/CT: Current Applications and Future Directions. Radiology 2006; 238(2): 405-422.
16. Cremerius U, Wildberger JE, Borchers H, et al. Does Positron Emission Tomography Using 18-Fluoro-2-Deoxyglucose Improve Clinical Staging of Testicular Cancer? Results of a Study in 50 Pa-tients. Urology 1999; 54(5): 900-904.
17. Pohl HG, Shukla AR, Metcalf PD, et al. Prepubertal Testis Tumors: Actual Prevalence Rate of Histo-logical Types. J Urol 2004; 172(6 Part 1): 2370-2372.
18. Lee, S. D. Epidemiological and Clinical Behavior of Prepubertal Testicular Tumors in Korea. J Urol 2004; 172(2): 674-678.
19. Shaikh F, Cullen JW, Olson TA, et al. Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents with Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report from the Children’s Oncology Group. J. Clin. Oncol 2017; 35(11): 1203-1210.
20. Bîcă O, Sârbu I, Ciongradi CI. Pediatric and Adolescent Oncofertility in Male Patients-from Alpha to Omega. Genes (Basel) 2021; 12(5): 701.
21. Tuluwengjiang G, Rasulova I, Ahmed S, et al. Dendritic Cell-Derived Exosomes (Dex): Underlying the Role of Exosomes Derived from Diverse DC Subtypes in Cancer Pathogenesis. Pathol Res Pract 2024; 254(155097): 155097.

Additional Files
Published
Issue
Section
License
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form